INTERVIEW: Elliott Sigal - stretching R&D dollars and leveraging data at BMS
This article was originally published in Scrip
Elliott Sigal is a winner. He came top of a December 2012 Scrip Intelligence analysis that identified the best R&D chief in the pharma industry (of recent times). Bristol-Myers Squibb’s executive vice-president and chief scientific officer beat off a challenge from several other candidates including Novartis's Mark Fishman, Amgen's Roger Perlmutter, and Merck's Peter Kim.